Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Flupirtine in pain management: pharmacological properties and clinical use.
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group.
Evaluation of quality of life and fatigue in radiologically isolated syndrome.
A study to evaluate the effect of ultrasound treatment on nodules in multiple sclerosis patients.
CLIPPERS complicating multiple sclerosis causing concerns of CNS lymphoma.
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses.
Brain-gut axis and pentadecapeptide BPC 157. Theoretical and practical implications.
Developmental Origin of Oligodendrocyte Lineage Cells Determines Response to Demyelination and Susceptibility to Age-Associated Functional Decline.
Interferon beta treatment of multiple sclerosis increases serum interleukin-7.
Atypical facial pain in multiple sclerosis caused by spinal cord seizures: a case report and review of the literature.
Treatment Burden and Chronic Illness: Who is at Most Risk?
Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study.
Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial.
Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage Progression.
Beta-Interferon, Glatiramer Acetate Cost-Effective in MS
Radiologically isolated syndrome: 5-year risk for an initial clinical event.
Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis.
Burden of neurological conditions in Canada.
Zebrafish as a model to investigate CNS myelination.
Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome.
The effects of prolonged wear of textured shoe insoles on gait, foot sensation and proprioception in people with multiple sclerosis: study protocol for a randomised controlled trial.
Long-term effectiveness of glatiramer acetate in clinical practice conditions.
VLA-4/CD49d downregulated on primed T lymphocytes during interferon-beta therapy in multiple sclerosis.
Vitamin D3 attenuates oxidative stress and cognitive deficits in a model of toxic demyelination.
Boxed warning of HBV risk added to Rituxan, Arezerra
Pages
« first
‹ previous
…
36
37
38
39
40
41
42
43
44
…
next ›
last »